Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MDSO

Medidata Solutions (MDSO) Stock Price, News & Analysis

Medidata Solutions logo

About Medidata Solutions Stock (NASDAQ:MDSO)

Key Stats

Today's Range
$92.21
$92.26
50-Day Range
$91.79
$92.25
52-Week Range
$60.10
$98.60
Volume
7.30 million shs
Average Volume
1.24 million shs
Market Capitalization
$5.76 billion
P/E Ratio
96.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.

Receive MDSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medidata Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDSO Stock News Headlines

Medidata announces new enterprise agreement with Bioforum
JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Cogstate Partners with Medidata for Strategic Growth
Transforming clinical trial experiences
See More Headlines

MDSO Stock Analysis - Frequently Asked Questions

Medidata Solutions Inc (NASDAQ:MDSO) announced its quarterly earnings data on Monday, July, 22nd. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.31. The company's quarterly revenue was up 15.8% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medidata Solutions investors own include Meta Platforms (META), NVIDIA (NVDA), Applied Materials (AMAT), Salesforce (CRM), Gilead Sciences (GILD), Bristol-Myers Squibb (BMY) and Allergan (AGN).

Company Calendar

Last Earnings
7/22/2019
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Prepackaged Software
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDSO
CUSIP
58471A10
Fax
N/A
Employees
1,998
Year Founded
N/A

Profitability

Net Income
$51.92 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$635.70 million
Cash Flow
$1.69 per share
Book Value
$10.32 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.76 billion
Optionable
Optionable
Beta
1.22
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:MDSO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners